Skip to content
Screener

Disc Medicine IRON Q2 2025 earnings

Reported August 7, 2025 · Before market open

EPS-$1.58Miss by $0.41
EPS estimate-$1.17

Next report

Nov 5, 2026 (in 3 months)
Revenue estimate$1.9M
EPS estimate-$1.64

Financials

Q2 2025

Income statement

See full
Operating income-$61.4M-99.0%
Net income-$55.2M-110%
EPS (diluted)-$1.58-53.4%

Balance sheet

See full
Cash & equivalents$127.3M-54.6%
Total debt$30.9M+1,583%
Total equity$614.2M+25.6%
Total assets$665.1M+30.3%

Cash flow

See full
Operating cash flow-$47.9M-211%
CapEx$36.0K—
Free cash flow-$48.0M-212%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.9B+70.4%
Enterprise value$1.81B+115%

Returns & leverage

See full
Return on equity-26.4%+8.6pp
Debt / equity0.1×0.0×
Current ratio32.1×+7.1×

FAQ

When did Disc Medicine report Q2 2025 earnings?
Disc Medicine (IRON) reported Q2 2025 earnings on August 7, 2025 before market open.
What were Disc Medicine's Q2 2025 revenue and EPS?
Disc Medicine reported eps of $-1.58 for Q2 2025.
Did Disc Medicine beat estimates in Q2 2025?
EPS missed the consensus estimate of $-1.17 by $0.41.
How did Disc Medicine's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 53.4% from $-1.03.
Where can I find Disc Medicine's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001816736-25-000006) and the 10-Q periodic report (0001816736-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.